7-51025327-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015198.5(COBL):c.3550G>A(p.Ala1184Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,613,342 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015198.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COBL | NM_015198.5 | c.3550G>A | p.Ala1184Thr | missense_variant | 12/13 | ENST00000265136.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COBL | ENST00000265136.12 | c.3550G>A | p.Ala1184Thr | missense_variant | 12/13 | 1 | NM_015198.5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152090Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000205 AC: 51AN: 248512Hom.: 0 AF XY: 0.000185 AC XY: 25AN XY: 134994
GnomAD4 exome AF: 0.000145 AC: 212AN: 1461134Hom.: 0 Cov.: 34 AF XY: 0.000146 AC XY: 106AN XY: 726888
GnomAD4 genome AF: 0.000138 AC: 21AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74410
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.3550G>A (p.A1184T) alteration is located in exon 12 (coding exon 12) of the COBL gene. This alteration results from a G to A substitution at nucleotide position 3550, causing the alanine (A) at amino acid position 1184 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at